BLCO250516C10000
- 1.70
- -0.60-26.09%
Bausch + Lomb Corp. Newsroom
Bausch + Lomb 1Q Loss Widens on Higher Costs
Bausch + Lomb Drops After Guidance Cut Amid EnVista Recall
Earnings Call Summary | Bausch + Lomb Corp.(BLCO.US) Q1 2025 Earnings Conference
Bausch + Lomb Signals 4.5%-6.5% Revenue Growth for 2025 With Focus on Premium IOLs and Dry Eye Portfolio
Starbucks Posts Weak Earnings, Joins Super Micro Computer, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Bausch + Lomb Reports Q1 Loss
Earnings Flash (BLCO) Bausch + Lomb Posts Q1 Revenue $1.14B, Vs. FactSet Est of $1.15B
Bausch + Lomb Corp. | 8-K: Bausch + Lomb Announces First-Quarter 2025 Results
Express News | Bausch & Lomb Raises FY2025 Sales Guidance From $4.95B-$5.05B to $5.00B-$5.10B Vs $5.01B Est
Bausch & Lomb Q1 Adj. EPS $(0.07) Misses $0.03 Estimate, Sales $1.14B Miss $1.15B Estimate
Press Release: Bausch + Lomb Announces First-Quarter 2025 Results
Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Maintains Target Price $19
Wells Fargo Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Maintains Target Price $15
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Earnings Preview: BLCO to Report Financial Results Pre-market on April 30
Needham Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating
Express News | Needham Reiterates Hold on Bausch & Lombto Hold
Sector Update: Health Care Stocks Advance Thursday Afternoon
Sector Update: Health Care
Bausch + Lomb to Return EnVista Intraocular Lenses to Market After Voluntary Recall